| 产品描述: | CXCR7 antagonist-1 hydrochloride is a CXCR7 antagonist that inhibits the binding of the SDF-1 chemokine (also known as the CXCL12 chemokine) or I-TAC (also known as CXCL11) to the chemokine receptor CXCR7. CXCR7 antagonist-1 hydrochloride is useful in preventing tumor cell proliferation, tumor formation, inflammatory diseases, and many other diseases. |
| 靶点: |
CXCR7 |
| 体外研究: |
CXCR7 antagonist-1 hydrochloride (10 μM, intranasal instillation, once a day, 2 doses) 可在 BALB/c 小鼠模型中抑制 RSV 感染引起的气道平滑肌松弛[2]。 |
| 体内研究: |
CXCR7 antagonist-1 hydrochloride (10 μM, 48 h) 可恢复 CXCL11 或呼吸道合胞病毒 (RSV) 感染引起的 β2-肾上腺素受体 (β2AR) 下调和婴儿气道平滑肌细胞的肌肉松弛。 |
| 参考文献: |
1. Junfa Fan, et al. Cxcr7 antagonists. Patent WO2014085490A1. 2. Zhao C, et al., Infant RSV infection desensitizes β2-adrenergic receptor via CXCL11-CXCR7 signaling in airway smooth muscle. bioRxiv [Preprint]. 2025 Jan 15:2025.01.13.632772. |
| 保存条件: |
-80°C 12个月; -20°C 6个月, 干燥 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.343 ml |
11.713 ml |
23.426 ml |
| 5 mM |
0.469 ml |
2.343 ml |
4.685 ml |
| 10 mM |
0.234 ml |
1.171 ml |
2.343 ml |
| 50 mM |
0.047 ml |
0.234 ml |
0.469 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |